?
Glocer Thomas H
Director
Merck & Co., Inc.
US, Kenilworth [HQ]
CIK
1140799
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
111,237,787
Price per Share :
$24.33
Equivalence :
$2,706,415,357.71
Transaction History
-
A111,237,787 Shares After TransactionValue : $n/a$0.0Transaction Date : 06/01/24
-
Footnotes
-
-
Footnotes:#1 Restricted Stock Units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which are convertible into shares of Common Stock at a ratio of 1 to 1.#2 Deferred stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan in lieu of cash retainers paid for service on the Morgan Stanley Board of Directors. Stock units are convertible into shares of Common Stock at a ratio of 1 to 1.
-
A112,266,746 Shares After TransactionValue : $10,911,205,043.74$100,004,525.21Transaction Date : 06/01/24
-
Footnotes
-
-
Footnotes:#1 Restricted Stock Units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which are convertible into shares of Common Stock at a ratio of 1 to 1.#2 Deferred stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan in lieu of cash retainers paid for service on the Morgan Stanley Board of Directors. Stock units are convertible into shares of Common Stock at a ratio of 1 to 1.
-
A114,772,154 Shares After TransactionValue : $15,154,515,214.16$100,003,662.96Transaction Date : 12/01/24
-
Footnotes
-
-
Footnotes:#1 Deferred stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan in lieu of cash retainers paid for service on the Morgan Stanley Board of Directors. Stock units are convertible into shares of Common Stock at a ratio of 1 to 1.